This finding was corroborated with genomics data involving 523 HNSCC patients in the cBio Portal for Cancer Genomics data set, showing a clinically relevant positive correlation of CD109 expression with the expression of IL6Rα, NRF2 and NRF2 target genes. The gene discussed is CD109; the disease is head and neck squamous cell carcinoma.